advertisement
Chen W 26
Showing records 1 to 25 | Display all abstracts from Chen W98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Wang QW
International Journal of Ophthalmology 2022; 15: 65-70
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang F
Molecular Therapy 2022; 30: 1421-1431
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Ye WQ
Chinese Journal of Ophthalmology 2022; 58: 35-40
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Zuo CG
International Journal of Ophthalmology 2022; 15: 65-70
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Deng YX
Chinese Journal of Ophthalmology 2022; 58: 35-40
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Zhuang P
Molecular Therapy 2022; 30: 1421-1431
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Li J
International Journal of Ophthalmology 2022; 15: 65-70
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Feng X
Molecular Therapy 2022; 30: 1421-1431
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Zuo JJ
Chinese Journal of Ophthalmology 2022; 58: 35-40
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu P
Molecular Therapy 2022; 30: 1421-1431
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Lin XS
International Journal of Ophthalmology 2022; 15: 65-70
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Zhang SD; Wang HO
Chinese Journal of Ophthalmology 2022; 58: 35-40
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu D
Molecular Therapy 2022; 30: 1421-1431
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Chen W
International Journal of Ophthalmology 2022; 15: 65-70
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Li JY
Chinese Journal of Ophthalmology 2022; 58: 35-40
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Huang H
Molecular Therapy 2022; 30: 1421-1431
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Zhu QL
International Journal of Ophthalmology 2022; 15: 65-70
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Li L
Molecular Therapy 2022; 30: 1421-1431
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Zheng QX
Chinese Journal of Ophthalmology 2022; 58: 35-40
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Zhou FQ; Lin HT
International Journal of Ophthalmology 2022; 15: 65-70
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Chen W
Molecular Therapy 2022; 30: 1421-1431
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Liang YB
Chinese Journal of Ophthalmology 2022; 58: 35-40
98578 Effectiveness of surgical management of malignant glaucoma in phakic eyes
Chen WR
International Journal of Ophthalmology 2022; 15: 65-70
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu L
Molecular Therapy 2022; 30: 1421-1431
98440 Clinical characteristics of 114 patients with iridocorneal endothelial syndrome
Chen W
Chinese Journal of Ophthalmology 2022; 58: 35-40
